Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment.
about
Psychotropic analgesic nitrous oxide for alcoholic withdrawal statesNeurobiological investigations into the role of cholecystokinin in panic disorderEtiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacksThe effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorderResearch applications of magnetic resonance spectroscopy to investigate psychiatric disorders.Feedback of end-tidal pCO2 as a therapeutic approach for panic disorderHyperventilation in panic disorder and asthma: empirical evidence and clinical strategiesRespiratory dysregulation in anxiety, functional cardiac, and pain disorders. Assessment, phenomenology, and treatment.Stress, ethanol, and neuroactive steroidsTheoretical and therapeutic considerations for the anxiety disorders.The Association between Baseline Subjective Anxiety Rating and Changes in Cardiac Autonomic Nervous Activity in Response to Tryptophan Depletion in Healthy VolunteersManagement of panic disorders.Validating the inhalation of 7.5% CO(2) in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD).The cholecystokinin hypothesis of panic and anxiety disorders: a review.Panic disorder and the respiratory system: clinical subtype and challenge tests.The carbon dioxide challenge test in panic disorder: a systematic review of preclinical and clinical research.Carbon dioxide chemosensitivity in panic disorder.The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures.A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.Elevated brain lactate responses to neural activation in panic disorder: a dynamic 1H-MRS study.A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers.Panic disorder: from respiration to the homeostatic brain.Yohimbine premedication and 35% CO2 vulnerability in healthy volunteers.Prefrontal hemodynamic after-effects caused by rebreathing may predict affective states - A multimodal functional near-infrared spectroscopy study.Effects of breathing training on voluntary hypo- and hyperventilation in patients with panic disorder and episodic anxiety.A 35% carbon dioxide challenge in simple phobias.Attenuation of carbon dioxide-induced panic after clonazepam treatment.Evidence for respiratory and nonrespiratory subtypes in panic disorder.Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures.
P2860
Q24245367-B0927FD5-3A80-4196-9C90-46DE75D1DF06Q24535665-2F89F71B-F1C1-4E6B-819D-3A1F1EA7774FQ27026213-0536EA3E-1279-42F3-AD81-A20B6344CBC4Q28296985-A32B9E09-7112-4A3E-9B42-C94ACB94852EQ33429548-DC2FC126-9C0C-4639-A13E-DD3AADACBFEEQ33931367-0E6E2329-DCC8-4FB0-A9C9-EB8ADE75A47DQ34117711-42A2F45E-EA9A-4BB2-94B0-9034E640CFF2Q34351929-8864D70B-6CB7-44E1-99F8-C32840B42C77Q34395828-2649D731-8E3B-4F15-9071-445C342241B3Q35274922-B30C974F-3B5D-4EDB-842F-CAF5676B1C62Q36993358-2449D0DA-DA2E-4AFB-9E36-AFBC86885725Q37042373-598C5042-2C59-4F0C-A6B0-A85E235BB6D0Q37945155-C3EC84C1-F206-42D2-B27B-A6A88F0EEA61Q37980110-4B1DF850-A464-4214-B504-70C76F21FBFEQ38021370-DA64AAB8-C58A-41E1-9CCC-343245390DCAQ38154176-A04FFA84-E759-42F2-98D3-A18BB1F0B5BBQ43725320-32189D40-2A17-4F64-AD7C-99C460FA7E61Q46334050-67D31BC2-83D5-407F-A22B-4AC8F23D7620Q46533458-D33A7130-58E1-4930-8925-D0F12CA27990Q46794381-C88E0C5F-4392-41DE-98F3-54108167A66AQ46988489-2347BE41-243E-4B47-B94D-0A81340F9C9BQ47347645-54184431-1932-45A5-B703-1C18FA2E6551Q48221695-8A5A6FBB-19CC-42E9-9EDD-08974BAD3885Q48865171-7DA70FF6-D080-4843-BA56-8DA0204BC43BQ50640266-6EA61F2D-8AFA-4943-8EF3-BF8C24A1E9E4Q51129521-F8279A16-B656-4539-B16C-3B79F05A3F74Q51155455-BE3C9C1A-303D-4DAB-9D84-D022099B43B1Q51914844-73426E11-E1D2-453D-849F-A85FFA92FD92Q52046171-4D4C8F58-1DC6-4659-B933-A3CD732BED32
P2860
Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Carbon dioxide sensitivity in ...... nd after alprazolam treatment.
@en
type
label
Carbon dioxide sensitivity in ...... nd after alprazolam treatment.
@en
prefLabel
Carbon dioxide sensitivity in ...... nd after alprazolam treatment.
@en
P2093
P1433
P1476
Carbon dioxide sensitivity in ...... nd after alprazolam treatment.
@en
P2093
P304
P356
10.1001/ARCHPSYC.1986.01800090090013
P407
P577
1986-09-01T00:00:00Z